[THE INVESTOR] South Korean Access Bio will be receiving US$1.83 million funds from the Bill & Melina Gates Foundation for research purposes.
The research period will be between September 2016 and January 2018.
The funding will be used to fine-tune the firm’s Ultra-HST platform technology it developed for speedy and accurate diagnosis of malaria -- even in patients who fail to show symptoms.
In March, Access Bio had received a US$800 million fund from the Global Health Investment Fund created by the Bill Gates Foundation.
By Kim Ji-hyun(jemmie@heraldcorp.com)
The research period will be between September 2016 and January 2018.
The funding will be used to fine-tune the firm’s Ultra-HST platform technology it developed for speedy and accurate diagnosis of malaria -- even in patients who fail to show symptoms.
In March, Access Bio had received a US$800 million fund from the Global Health Investment Fund created by the Bill Gates Foundation.
By Kim Ji-hyun(jemmie@heraldcorp.com)
